All Stories

  1. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort

    Article • BMC Infectious Diseases, July 2016, Springer Science + Business Media

    PhD Francesco Nicoli

  2. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection

    Article • Vaccine, April 2016, Elsevier

    PhD Francesco Nicoli

  3. Bystander hyperactivation of preimmune CD8 + T cells in chronic HCV patients

    Article • eLife, November 2015, eLife

    PhD Francesco Nicoli

  4. Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide

    Article • Human Vaccines & Immunotherapeutics, April 2015, Taylor & Francis

    PhD Francesco Nicoli

  5. Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs

    Article • AIDS, January 2015, Wolters Kluwer Health

    PhD Francesco Nicoli

  6. HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors

    Article • AIDS, July 2014, Wolters Kluwer Health

    PhD Francesco Nicoli

  7. The HIV-1 Tat Protein Induces the Activation of CD8+ T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses

    Article • PLoS ONE, November 2013, PLOS

    PhD Francesco Nicoli

  8. The HIV Tat protein favors the activation of CD8 T cells thus contributing to HIV-related immune dysfunctions

    Article • Frontiers in Immunology, January 2013, Frontiers

    PhD Francesco Nicoli